Increasing the amount of physical activity has been observed to ameliorate the progression of Alzheimer's disease (AD), as well as enhance neurogenesis. Choi et al. in this issue of Neuron report that the expression of Presenilin 1 (PS1) variants, responsible for the early onset of familial AD, are capable of mitigating the regenerative effects associated with increased activity and environmental enrichment likely through changes in resident microglia and their secreted factors.
Normal aging in humans brings with it a progressive loss in memory and other cognitive functions and is often exacerbated by diseases such as AD. Creating hope that this bleak outlook can be challenged, a growing number of studies suggest that increasing the amount of physical activity can reduce the risk and slow the progression of AD (Larson et al., 2006; Pope et al., 2003) . Equally fascinating have been reports in rodents that during normal aging as well as in young adults, increased activity and environmental enrichment (EE) can lead to an increase in the number, and functional output, of neural stem cell populations in the brain (van Praag et al., 2005) . While the parallels between the human and rodent studies are intriguing, more work is necessary to causally link EE and physical activity with increased neurogenesis and cognitive function in experimental models and demonstrate its relevance to humans. In this issue of Neuron, Choi et al. (2008) add a number of unexpected findings to our understanding of EE-induced neurogenesis that might have relevance for aging and possibly AD. They report that PS1 variants causing early-onset familial AD alter the neurogenic niche in the adult mouse brain through changes in microglia that spoil the regenerative benefits associated with increased physical activity and EE.
Stem cells in the adult brain have been observed in mammals, including humans, primarily in the subventricular zone (SVZ) of the lateral ventricles and the subgranular zone (SGZ) of the hippocampus (Lois and Alvarez-Buylla, 1993) . Adult neural stem/progenitor cells (NPCs) are a relatively quiescent population that can selfrenew and give rise to more rapidly dividing progenitors that in turn produce neurons (neurogenesis), as well as astrocytes and oligodendrocytes (gliogenesis). Neurons born in the SGZ can become granule neurons that integrate into the existing circuitry of the hippocampus and have been shown increasingly to influence learning and memory (Dupret et al., 2007) . Previous studies have also established that adult NPCs are localized to specialized microenvironments-or neurogenic niches-composed of surrounding cells including astrocytes, oligodendrocytes, microglia, and endothelial cells, as well as soluble factors, membrane-bound molecule,s and extracellular matrix molecules. Together, the neurogenic niche is thought to provide the permissive cues necessary for NPC maintenance, differentiation, and neural integration into the circuitry of the brain (Alvarez- Buylla and Lim, 2004) .
The promise that increased neurogenesis in the adult brain could indeed stimulate cognitive performance and that EE or physical activity may be sufficient to trigger neurogenesis opened the questions whether adult neurogenesis is impaired in illnesses with cognitive dysfunction such as AD, but also whether EE could be exploited to stave off age-related cognitive decline and neurodegeneration. To date, proteins involved in the early-onset genetic forms of AD, including mutant amyloid precursor protein (APP) and PS1, have been reported to interfere with NPC function in a number of mouse models, both under normal and enriched conditions (Kuhn et al., 2007) . Of special relevance to the current article, Feng et al. (2001) have shown that targeted deletion of endogenous PS1 in excitatory forebrain neurons in adult mice inhibits enrichment-induced neurogenesis in the dentate gyrus and also leads to changes in contextual fear memory functions. This earlier study suggested a cell-autonomous effect for PS1 in neurogenesis, but Choi et al. (2008) demonstrate now that in the context of familial AD with PS1 mutations microglia have a word as well.
The authors observed that PS1 mutations inhibited the enrichment-induced increase in NPC proliferation and differentiation and that this inhibition was associated with changes in microglial cell number and function (Figure 1 ). They examined the effect of wild-type human PS1 (PS1hWT) and FAD-linked mutant PS1 variants ubiquitously expressed under control of the prion protein promoter on the capacity of NPCs to proliferate and differentiate, both in vivo and in vitro. In agreement with other reports, EE resulted in a prominent increase in proliferating cells in the dentate gyrus in PS1hWT mice; however, this increase was absent in FAD-linked PS1 mutants. Under standard housing and activity conditions, these mutants had no significant effect on proliferation in the dentate gyrus ( Figure 1A) . Interestingly, if they analyzed the brains of those mice that showed a particular passion to run on the treadmill in their enriched housing conditions (>40% of the 3 hr daily enrichment time) PS1hWT mice had more dentate granule cells than their sedentary littermates (Figure 1B) ; again, the number of granule cells in mice expressing PS1 variants was significantly reduced. This reduction was not due to alterations in APP metabolism (mutant PS1 increases production of highly amyloidogenic and presumably neurotoxic Ab derived from APP), since PS1 mice lacking APP showed similar patterns of changes. In addition, isolated NPCs from PS1hWT or PS1 mutant mice showed no differences in proliferation pointing toward non-cell-autonomous effects on NPCs.
Because high-activity EE also resulted in a significant increase in the number of microglia in the hippocampus of PS1hWT mice but caused no change in microglia numbers in mice expressing PS1 variants, the authors hypothesized that microglia may have a role in modulating NPC function. Microglia, which are the main immune cells of the brain derived from the myeloid lineage, seem to have a particularly interesting function in the neurogenic niche. Under homeostatic conditions, resident microglia have been found to support the generation of new neurons, whereas inflammation can turn them into strong inhibitors of neurogenesis (Monje et al., 2003; Ziv and Schwartz, 2008) . Thus, more hippocampal neurogenesis observed with increased physical activity and EE has been linked to a pronounced increase in activated, presumably beneficial microglia, and blocking this activity by immunosuppressive drugs impaired their neurogenic, regenerative function (Ziv et al., 2006) .
Although they could not establish a direct causal relationship between microglial changes and neurogenesis in vivo, Choi and colleagues (2008) present a series of intriguing cell culture experiments that link PS1 mutations in microglia to changes in the secretory profile of signaling proteins and in turn to NPC function (Figure 1 ). They show that microglia isolated from PS1hWT mice or supernatants from these cells promote proliferation of primary mouse NPCs, whereas microglia expressing PS1 variants retard proliferation. This effect is observed both when microglia are in a resting state or when they are activated by interleukin-4 (IL-4)-a cytokine that has been proposed to steer microglia toward a neurogenic function mimicking EE (Ziv et al., 2006) . Similar results were obtained with organotypic hippocampal slice cultures, suggesting that microglia secrete soluble factors that regulate neurogenesis. The precise role or possible origin of IL-4 in neurogenesis and in the CNS in general is poorly defined, but this cytokine may open an interesting tool to modulating microglial function. Of note and as pointed out by the authors, PS1 mutant-derived microglial factors promoted differentiation of NPCs into GFAP-positive glia in cell culture, but this was not observed in vivo ( Figure 1C ). While this suggests differences in the two model systems exist, it should not distract from the observation that neurogenesis is reduced in vitro and 
. Neurogenesis Is Induced by High-Activity EE and Modulated by Changes in Microglia
High-activity EE is defined as EE conditions in which mice spent >40% of time on a running wheel. (A) Under standard housing conditions, the ubiquitous expression of PS1hWT or PS1 variants does not interfere with adult neurogenesis. (B) EE and running in particular increases in the number of microglia, NPCs, and neurogenesis, and this is not disrupted by the expression of PShWT. (C) Expression of PS1 variants mitigates the effects of high activity EE. The number of microglia, NPC proliferation, and neurogenesis within the neurogenic niche of the hippocampus are decreased. Changes in the secreted factors from microglia (derived from PS1 variant transgenic mice) are sufficient to inhibit wildtype NPC proliferation and neurogenesis, as well as preferentially lead to glia differentiation in vitro.
in vivo in the context of PS1 mutant expression. Still, the more general question remains whether microglia are indeed directly responsible for the observed inhibition of EE-induced neurogenesis by PS1 and which factors mediate this effect.
Toward the latter question, the authors use an innovative way to survey changes in 62 different cytokines and secreted signaling molecules in conditioned media from resting and IL-4-activated PS1hWT and mutant microglia using antibodybased filter arrays. A number of interesting leads were found to be increased at the transcript and protein level in PS1 mutant microglia, including tissue inhibitor of metalloproteinase-1 (TIMP)-1, the chemokines CCL5 and CXCL1, as well as IL-6, some of which have previously been implicated in NPC biology. Remarkably, freshly isolated microglia from EE-housed mice seem to have different levels of expression for some of these factors and show evidence of activation by IL-4. These findings are exciting and offer much food for thought and future experiments. They also expose our rudimentary understanding of microglia biology and the role of classical immune signaling molecules in neurogenesis and probably CNS function in general.
While this study begins to elucidate the role of microglia, and subsequently their secreted factors, as potential avenues of NPC regulation, such in vitro results must be validated in an in vivo model. Microglia have been unmasked recently to contribute to the disease process in superoxide dismutase (SOD) 1 mouse models of amyotophic lateral sclerosis by deleting this gene in microglia and thus extending survival (Boillee et al., 2006) . Perhaps developing genetic models in which PS1 variants are expressed exclusively by microglia may lead to additional insights into how changes in resident microglia of the hippocampus directly influence adult NPCs in vivo. Such models may also prove integral in elucidating at a cellular level how presenilin mutations cause these microglial changes. According to the authors, APP or notch signaling are not involved. Additionally, applying such genetic models toward behavioral studies may help to tease apart how changes to the neurogenic niche lead to cognitive impairments.
In the end, the findings by Choi and coworkers also serve to highlight the importance of the neurogenic niche, in which non-cell-autonomous signaling changes may help to explain the diminishing regenerative potential attributed to other variables such as aging and possibly neurodegeneration itself. It is therefore most interesting to ask how other components of the neurogenic niche may contribute to the (mis)regulation and decline of NPC function with age and disease and whether some of these cues may even come from the periphery. Indeed, changes in the activity of microglia induced by EE may reflect more global changes in the organism itself. Identifying how changes to the molecular composition of the neurogenic niche regulate the activity of NPC populations may provide opportunities toward the development of regenerative therapeutics to directly combat both degenerative disease and normal age-related impairments.
